VSEE HEALTH, INC. 8-K

What Happened VSee Health, Inc. (VSEE) filed an 8-K reporting two related transactions with GoMyRx, Inc. (GMRx). On December 26, 2025 VSee and its subsidiary iDoc entered a Managed Services Agreement to provide platform administration, customer/user support, third‑party vendor coordination and reporting/governance to GMRx. On January 16, 2026 VSee agreed to purchase $2.0 million of GMRx common stock—representing a 10% ownership interest—in a private, Rule 506/Section 4(a)(2) exempt transaction.

Key Details

• Managed Services Agreement dated December 26, 2025: VSee will invoice GMRx monthly for actual expenses incurred plus a 10% markup. Term through December 26, 2027, with option to extend month‑to‑month up to six additional months; GMRx may terminate with 20 days’ written notice.
• Stock Purchase Agreement dated January 16, 2026: VSee purchased $2.0 million of GMRx common stock for a 10% stake. Shares bear restrictive legends and are subject to securities law transfer restrictions.
• GMRx is described as a digital prescription fulfillment platform and an affiliate within the GoMyDocs ecosystem.
• Transactions were private and relied on securities exemptions (Section 4(a)(2) and Rule 506).

Why It Matters These actions create both a commercial services relationship and an equity investment between VSee and GMRx. For investors, the MSA provides a potential recurring revenue stream (expense reimbursement plus a 10% fee) tied to services VSee will perform, while the $2.0M stock purchase gives VSee a minority ownership stake (10%) in GMRx. The agreements are time‑limited and include short termination/extension provisions, so the arrangements are not an indefinite commitment. The filing notes that GMRx is an affiliate in the GoMyDocs ecosystem, which is relevant when assessing related‑party relationships and strategic alignment.